📊 USPH Key Takeaways
Is U S Physical Therapy Inc. /N.V. (USPH) a Good Investment?
US Physical Therapy faces structural operational challenges with zero revenue growth, negative free cash flow (-1.6M), and razor-thin net margins of 2.5%. Despite 26% net income growth, sharply declining EPS (-22.8%) signals substantial shareholder dilution, indicating the company is struggling to maintain operations without capital destruction.
U S Physical Therapy Inc. /N.V. Key Strengths (USPH)
- Net income grew 26% YoY, showing some profitability improvement
- Moderate leverage with 0.41x debt/equity ratio and acceptable interest coverage of 6.0x
- Current ratio of 1.19x provides adequate short-term liquidity for operational continuity
USPH Stock Risks: U S Physical Therapy Inc. /N.V. Investment Risks
- Negative free cash flow (-1.6M) indicates cash burn despite operational status - unsustainable long-term
- Revenue flatlined at 0.0% YoY growth, indicating loss of market share or stalled expansion in healthcare services
- Extremely poor returns: 1.1% ROE and 0.4% ROA reflect severe operational inefficiency and asset underutilization
- EPS declining 22.8% despite net income growth signals excessive shareholder dilution masking operational weakness
- Minimal cash position (28.4M) relative to 194M long-term debt limits financial flexibility and refinancing options
Key Metrics to Watch
- Free cash flow trajectory - critical inflection point for business viability
- Operating cash flow to revenue ratio - current 1.9% is unsustainably low
- Revenue growth rate - must return to positive growth to service debt sustainably
U S Physical Therapy Inc. /N.V. (USPH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
U S Physical Therapy Inc. /N.V. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
USPH Profit Margin, ROE & Profitability Analysis
USPH vs Services Sector: How U S Physical Therapy Inc. /N.V. Compares
How U S Physical Therapy Inc. /N.V. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is U S Physical Therapy Inc. /N.V. Stock Overvalued? USPH Valuation Analysis 2026
Based on fundamental analysis, U S Physical Therapy Inc. /N.V. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
U S Physical Therapy Inc. /N.V. Balance Sheet: USPH Debt, Cash & Liquidity
USPH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: U S Physical Therapy Inc. /N.V.'s revenue has grown significantly by 58% over the 5-year period, indicating strong business expansion. The most recent EPS of $1.28 reflects profitable operations.
USPH Revenue Growth, EPS Growth & YoY Performance
USPH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $183.8M | $5.0M | $-0.12 |
| Q3 2025 | $168.0M | $6.6M | $0.39 |
| Q2 2025 | $167.2M | $7.5M | $0.47 |
| Q1 2025 | $155.7M | $8.0M | $0.46 |
| Q3 2024 | $150.0M | $6.6M | $0.39 |
| Q2 2024 | $151.5M | $7.5M | $0.47 |
| Q1 2024 | $148.5M | $7.4M | $0.46 |
| Q3 2023 | $139.6M | $9.3M | $0.51 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
U S Physical Therapy Inc. /N.V. Dividends, Buybacks & Capital Allocation
USPH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for U S Physical Therapy Inc. /N.V. (CIK: 0000885978)
📋 Recent SEC Filings
❓ Frequently Asked Questions about USPH
What is the AI rating for USPH?
U S Physical Therapy Inc. /N.V. (USPH) has an AI grade of C with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are USPH's key strengths?
Claude: Net income grew 26% YoY, showing some profitability improvement. Moderate leverage with 0.41x debt/equity ratio and acceptable interest coverage of 6.0x.
What are the risks of investing in USPH?
Claude: Negative free cash flow (-1.6M) indicates cash burn despite operational status - unsustainable long-term. Revenue flatlined at 0.0% YoY growth, indicating loss of market share or stalled expansion in healthcare services.
What is USPH's revenue and growth?
U S Physical Therapy Inc. /N.V. reported revenue of $198.3M.
Does USPH pay dividends?
U S Physical Therapy Inc. /N.V. pays dividends, with $27.4M distributed to shareholders in the trailing twelve months.
Where can I find USPH SEC filings?
Official SEC filings for U S Physical Therapy Inc. /N.V. (CIK: 0000885978) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is USPH's EPS?
U S Physical Therapy Inc. /N.V. has a diluted EPS of $-0.12.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is USPH's fundamental grade?
Based on our AI fundamental analysis in June 2026, U S Physical Therapy Inc. /N.V. has a C grade with 78% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is USPH stock overvalued or undervalued?
Valuation metrics for USPH: ROE of 1.1% (sector avg: 16%), net margin of 2.5% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is USPH's AI grade for 2026?
Our dual AI analysis gives U S Physical Therapy Inc. /N.V. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is USPH's free cash flow?
U S Physical Therapy Inc. /N.V.'s operating cash flow is $3.8M, with capital expenditures of $5.4M. FCF margin is -0.8%.
How does USPH compare to other Services stocks?
Vs Services sector averages: Net margin 2.5% (avg: 10%), ROE 1.1% (avg: 16%), current ratio 1.19 (avg: 1.5).